Skip to main content

Table 1 Baseline characteristics of patients with COVID-19 by dementia stat us

From: Dementia and psychotropic medications are associated with significantly higher mortality in geriatric patients hospitalized with COVID-19: data from the StockholmGeroCovid project

 

COVID-19 yes (first admission with COVID-19)

Dementia (762)

Dementia-free (4360)

p

Age at admission, years

84.3 (7.4)

82.1 (8.6)

<0.001

Age group

<70

24 (3.1%)

335 (3.1%)

<0.001

70–79

167 (21.9%)

1354 (31.1%)

80–89

362 (47.5%)

1729 (39.7%)

>89

209 (27.4%)

942 (21.6%)

Male sex

345 (45.3%)

2080 (47.7%)

0.22

CCI group

0–1 points

572 (75.1%)

2576 (59.1%)

<0.001

2–3 points

160 (21.0%)

1298 (29.8%)

>3 points

30 (3.9%)

486 (11.1%)

SpO2

≥90%

688 (90.3%)

4050 (92.9%)

0.004

<90%

65 (8.6%)

252 (5.8%)

Missing

9 (1.1%)

58 (1.3%)

 

Beta blockers

311 (40.8%)

2283 (52.4%)

<0.001

Ca2+ channel blocker

192 (25.2%)

1354 (31.1%)

0.001

RAAS inhibitors

280 (36.7%)

2259 (51.8%)

<0.001

Statins

266 (34.9%)

1881 (43.1%)

<0.001

Antithrombotics

729 (95.7%)

4210 (96.6%)

0.22

Antipsychotics

199 (26.1%)

363 (8.3%)

<0.001

Antidepressants

288 (37.8%)

1043 (23.9%)

<0.001

Anxiolytics

304 (39.9%)

1100 (25.2%)

<0.001

Hypnotics/sedatives

425 (55.8%)

2073 (47.5%)

<0.001

COVID-19 wave

First wave

313 (41.1%)

1555 (35.7%)

<0.001

Second wave

328 (43.0%)

1768 (40.6%)

Third wave

121 (15.9%)

1037 (23.8%)

Main cause of hospitalization

COVID-19

630 (82.7%)

3756 (86.1%)

<0.001

Cardiovascular

11 (1.4%)

123 (2.8%)

Respiratory

18 (2.4%)

113 (2.6%)

Neurological

58 (7.6%)

61 (1.4%)

External (trauma, poison)

20 (2.6%)

80 (1.8%)

Others

25 (3.3%)

227 (5.2%)

Hospitalization duration, days

10.8 (6.8)

10.0 (6.9)

0.023

Discharged to home

316 (41.5%)

2904 (66.6%)

<0.001

In-hospital mortality

154 (20.2%)

394 (9.0%)

<0.001

Post-discharge mortality

30-day

73 (9.6%)

340 (7.8%)

0.097

90-day

108 (14.2%)

466 (10.7%)

0.006

365-day

166 (21.8%)

721 (16.5%)

0.001

Overall

183 (24.0%)

796 (18.3%)

<0.001

Total mortality (in-hospital + post-discharge)

337 (44.2%)

1190 (27.3%)

<0.001

  1. Age at admission is described as mean (SD). Other variables are described as n (%); SpO2 refers to the first oxygen saturation recorded during hospitalization. Attained comorbidities were recorded at admission and medication use was recorded at admission or at admission + 1 day. COVID-19 waves were divided based on dates—August 31, 2020 (first and second wave) and February 28, 2021 (second and third wave). Comparisons for scale variables across the dementia strata were performed using the independent-samples t-test (age at admission) and Mann-Whitney U-test (hospitalization duration). The chi-square test was used in all other descriptive analyses
  2. CCI Charlson Comorbidity Index, RAAS renin-angiotensin-aldosterone system